{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:19:16Z","timestamp":1771420756158,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"DOI":"10.7759\/cureus.103825","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:45:07Z","timestamp":1771418707000},"source":"Crossref","is-referenced-by-count":0,"title":["Poly-Infections in a Patient Living With Human Immunodeficiency Virus (HIV)"],"prefix":"10.7759","author":[{"given":"Annarose M","family":"Sorvillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim","family":"Belinschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Akkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihad","family":"Slim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline G","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0056","article-title":"Prevention and treatment of cancer-related infections, version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Baden LR","year":"2024","unstructured":"Baden LR, Swaminathan S, Almyroudis NG, et al.. Prevention and treatment of cancer-related infections, version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024, 22:617-44. 10.6004\/jnccn.2024.0056","journal-title":"J Natl Compr Canc Netw"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0026","article-title":"NCCN Guidelines\u00ae insights: hematopoietic growth factors, version 1.2022","volume":"20","author":"Griffiths EA","year":"2022","unstructured":"Griffiths EA, Roy V, Alwan L, et al.. NCCN Guidelines\u00ae insights: hematopoietic growth factors, version 1.2022. J Natl Compr Canc Netw. 2022, 20:436-42. 10.6004\/jnccn.2022.0026","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/20499361221138346","article-title":"Approach to fever in patients with neutropenia: a review of diagnosis and management","volume":"9","author":"Keck JM","year":"2022","unstructured":"Keck JM, Wingler MJ, Cretella DA, et al.. Approach to fever in patients with neutropenia: a review of diagnosis and management. Ther Adv Infect Dis. 2022, 9:20499361221138346. 10.1177\/20499361221138346","journal-title":"Ther Adv Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2014.893301","article-title":"Neutropenia during HIV infection: adverse consequences and remedies","volume":"33","author":"Shi X","year":"2014","unstructured":"Shi X, Sims MD, Hanna MM, et al.. Neutropenia during HIV infection: adverse consequences and remedies. Int Rev Immunol. 2014, 33:511-36. 10.3109\/08830185.2014.893301","journal-title":"Int Rev Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02429-21","article-title":"Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study","volume":"60","author":"Verway M","year":"2022","unstructured":"Verway M, Brown KA, Marchand-Austin A, et al.. Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study. J Clin Microbiol. 2022, 60:e0242921. 10.1128\/jcm.02429-21","journal-title":"J Clin Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad265","article-title":"Epidemiology of gram-negative bloodstream infections in the United States: results from a cohort of 24 hospitals","volume":"10","author":"Ince D","year":"2023","unstructured":"Ince D, Fiawoo S, Choudhury R, et al.. Epidemiology of gram-negative bloodstream infections in the United States: results from a cohort of 24 hospitals. Open Forum Infect Dis. 2023, 10:ofad265. 10.1093\/ofid\/ofad265","journal-title":"Open Forum Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe","volume":"19","author":"Goto M","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013, 19:501-9. 10.1111\/1469-0691.12195","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1786265","article-title":"Strongyloides hyperinfection syndrome combined with cytomegalovirus infection","volume":"2016","author":"Elzein FE","year":"2016","unstructured":"Elzein FE, Alsaeed M, Ballool S, Attia A. Strongyloides hyperinfection syndrome combined with cytomegalovirus infection. Case Rep Transplant. 2016, 2016:1786265. 10.1155\/2016\/1786265","journal-title":"Case Rep Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051172","article-title":"Co-occurrence of Helicobacter pylori and Candida spp. infections in the pathogenesis of gastrointestinal diseases","volume":"13","author":"Braksator J","year":"2025","unstructured":"Braksator J, Kofla-D\u0142ubacz A, Antosz-Popio\u0142ek K, et al.. Co-occurrence of Helicobacter pylori and Candida spp. infections in the pathogenesis of gastrointestinal diseases. Biomedicines. 2025, 13:10.3390\/biomedicines13051172","journal-title":"Biomedicines"},{"key":"ref10","unstructured":"Herpes simplex virus. (2023). Accessed. November 12, 2025: https:\/\/www.hopkinsguides.com\/hopkins\/view\/Johns_Hopkins_ABX_Guide\/540242\/all\/Herpes_Simplex_Virus."},{"key":"ref11","unstructured":"UpToDate. LexiDrug: Acyclovir. (2025). Accessed: November 12, 2025: https:\/\/online.lexi.com\/lco\/action\/login."},{"key":"ref12","unstructured":"Clinical Guidelines Program. ART drug-drug interactions: Rilpivirine (RPV) interactions. (2022). Accessed: November 24, 2025: https:\/\/cdn.hivguidelines.org\/wp-content\/uploads\/20221202123302\/NYSDOH-AI-ART-Drug-Drug-Interactions-RPV-Interactions...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf039","article-title":"Durability of doravirine\/dolutegravir dual combination in a multicentre cohort of elderly people with HIV","volume":"80","author":"Mazzitelli M","year":"2025","unstructured":"Mazzitelli M, Cozzolino C, Gervasoni C, et al.. Durability of doravirine\/dolutegravir dual combination in a multicentre cohort of elderly people with HIV. J Antimicrob Chemother. 2025, 80:1089-96. 10.1093\/jac\/dkaf039","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02075-y","article-title":"The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir","volume":"51","author":"Sammet S","year":"2023","unstructured":"Sammet S, Touzeau-R\u00f6mer V, Wolf E, et al.. The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir. Infection. 2023, 51:1823-9. 10.1007\/s15010-023-02075-y","journal-title":"Infection"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13615","article-title":"Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir-based dual combinations","volume":"25","author":"Rossotti R","year":"2024","unstructured":"Rossotti R, D'Amico F, Bana NB, et al.. Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir-based dual combinations. HIV Med. 2024, 25:675-83. 10.1111\/hiv.13615","journal-title":"HIV Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028488","article-title":"Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: a retrospective analysis","volume":"100","author":"Mazzitelli M","year":"2021","unstructured":"Mazzitelli M, Sasset L, Leoni D, Putaggio C, Cattelan AM. Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: a retrospective analysis. Medicine (Baltimore). 2021, 100:e28488. 10.1097\/MD.0000000000028488","journal-title":"Medicine (Baltimore)"},{"key":"ref17","unstructured":"Centers for Disease Control and Prevention. Clinical care of Strongyloides. (2025). Accessed: November 12, 2025: https:\/\/www.cdc.gov\/strongyloides\/hcp\/clinical-care\/index.html."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2001.00407.x","article-title":"HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis","volume":"23","author":"Porto AF","year":"2001","unstructured":"Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alc\u00e2ntara L, Carvalho EM. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001, 23:503-7. 10.1046\/j.1365-3024.2001.00407.x","journal-title":"Parasite Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9110904","article-title":"Human T-cell leukemia virus type 1 and Strongyloides stercoralis: partners in pathogenesis","author":"Dykie A","year":"2020","unstructured":"Dykie A, Wijesinghe T, Rabson A, et al.. Human T-cell leukemia virus type 1 and Strongyloides stercoralis: partners in pathogenesis. Pathogens. 2020, 10.3390\/pathogens9110904","journal-title":"Pathogens"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071307","article-title":"Large granular lymphocytic leukemia: clinical features, molecular pathogenesis, diagnosis and treatment","volume":"16","author":"Ullah F","year":"2024","unstructured":"Ullah F, Markouli M, Orland M, Ogbue O, Dima D, Omar N, Mustafa Ali MK. Large granular lymphocytic leukemia: clinical features, molecular pathogenesis, diagnosis and treatment. Cancers (Basel). 2024, 16:10.3390\/cancers16071307","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440459-poly-infections-in-a-patient-living-with-human-immunodeficiency-virus-hiv","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:45:09Z","timestamp":1771418709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440459-poly-infections-in-a-patient-living-with-human-immunodeficiency-virus-hiv"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103825","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}